Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
The contract research organization Frontage Laboratories has acquired rival Concord Biosciences for an undisclosed sum. Frontage’s 650 employees offer drug development services from 14 locations in the U.S. and China. Ohio-based Concord, formerly Ricerca Biosciences, will bolster Frontage’s preclinical, agrochemical, and toxicology services, says Frontage CEO Song Li. Concord has 65 employees. Olon acquired Ricerca’s chemical manufacturing division last year.
This article has been sent to the following recipient: